Establishment through persistent technical refinement and industrial-scale manufacturing capability, providing reliable chemical foundations for global markets.
Listed on the Shenzhen Stock Exchange GEM, opening a new chapter of innovation and development! Stock abbreviation: Hongyuan Pharmaceutical, stock code: 301246.
Revenue exceeded 2 billion yuan.
The first tax payment of more than 100 million yuan.
Listed in the national small and medium-sized enterprise share transfer system, stock code: 831265.
Development of "the use of fluid phase reaction method to produce lithium hexafluorophosphate technology", into new energy.
For the first time to obtain drug approval number (metronidazole), and in the same year for the first time through GMP certification.
We continue to optimize our manufacturing framework, integrating high-purity synthesis expertise with sustainable production protocols to drive global chemical supply excellence.
Partner With Us
